{"id":8086,"date":"2024-01-18T09:21:25","date_gmt":"2024-01-18T08:21:25","guid":{"rendered":"https:\/\/saniona.com\/?page_id=8086"},"modified":"2024-01-19T10:23:59","modified_gmt":"2024-01-19T09:23:59","slug":"prospekt","status":"publish","type":"page","link":"https:\/\/saniona.com\/sv\/investerare\/prospekt\/","title":{"rendered":"Prospekt"},"content":{"rendered":"

[et_pb_section fb_built=”1″ fullwidth=”on” disabled_on=”on|on|on” _builder_version=”4.16″ _module_preset=”default” disabled=”on” global_colors_info=”{}”][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.16″ _module_preset=”default” z_index=”1″ height=”56vh” height_tablet=”45vh” height_phone=”70vh” height_last_edited=”on|phone” global_colors_info=”{}”][et_pb_fullwidth_slider show_arrows=”off” use_bg_overlay=”off” admin_label=”Slider 03″ module_class=”home-slider-section single-pagebanner” _builder_version=”4.21.0″ _module_preset=”default” min_height=”56vh” min_height_tablet=”45vh” min_height_phone=”70vh” min_height_last_edited=”on|phone” custom_padding=”50px||||false|false” animation_style=”fade” custom_css_slide_description=”animation-name: none;” global_colors_info=”{}”][et_pb_slide use_bg_overlay=”off” use_text_overlay=”off” admin_title=”Slider 01″ _builder_version=”4.21.0″ _module_preset=”default” header_level=”h6″ header_font=”Nunito Sans|600|on||||||” header_text_color=”#ffffff” header_font_size=”16px” header_line_height=”1.1em” body_font=”DM Serif Display||||||||” body_text_color=”#ffffff” body_font_size=”50px” body_line_height=”1.3em” background_color=”#555758″ background_enable_color=”off” background_image=”https:\/\/saniona.com\/wp-content\/uploads\/2021\/04\/Saniona_Banner_Investors.jpg” background_enable_image=”on” parallax=”on” button_alignment=”left” width=”92%” custom_padding=”140px||||false|false” custom_padding_tablet=”140px||||false|false” custom_padding_phone=”40px||||false|false” custom_padding_last_edited=”on|phone” header_text_color_tablet=”” header_text_color_phone=”#555758″ header_text_color_last_edited=”on|phone” body_font_size_tablet=”46px” body_font_size_phone=”40px” body_font_size_last_edited=”on|phone” body_line_height_tablet=”54px” body_line_height_phone=”50px” body_line_height_last_edited=”on|tablet” background_last_edited=”off|desktop” background_image_tablet=”https:\/\/saniona.com\/wp-content\/uploads\/2021\/04\/saniona-tele.jpg” background_enable_image_tablet=”on” parallax_tablet=”off” background_position_tablet=”top_left” global_colors_info=”{}” title_text_tablet=”saniona-tele” sticky_transition=”on”]<\/p>\n

\n
Investerare<\/a><\/h6>\n

Prospekt<\/p>\n<\/div>\n

[\/et_pb_slide][\/et_pb_fullwidth_slider][\/et_pb_section][et_pb_section fb_built=”1″ module_class=”animation-with-menu” _builder_version=”4.18.0″ _module_preset=”default” custom_padding=”14px||0px|||” global_colors_info=”{}”][et_pb_row _builder_version=”4.18.0″ _module_preset=”default” vertical_offset=”0px” horizontal_offset=”0px” min_height=”70px” custom_padding=”||5px|||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/saniona.com\/wp-content\/uploads\/2021\/01\/Saniona_icon_lg_ltblue_new.png” alt=”Saniona Icon blue” title_text=”Saniona_icon_lg_ltblue_new” align_tablet=”” align_phone=”” align_last_edited=”on|phone” disabled_on=”on|off|off” _builder_version=”4.18.0″ _module_preset=”default” z_index=”-1″ width=”66%” width_tablet=”72%” width_phone=”” width_last_edited=”on|tablet” min_height=”644px” custom_margin=”-350px||-300px||false|false” custom_margin_tablet=”-280px||-300px||false|false” custom_margin_phone=”” custom_margin_last_edited=”on|tablet” custom_padding=”|0px|63px|||” filter_opacity=”70%” animation_style=”fade” animation_direction=”bottom” animation_duration=”1400ms” animation_delay=”200ms” scroll_rotating_enable=”on” scroll_rotating=”60|84|84|100|0\u00b0|30\u00b0|90\u00b0” module_alignment_tablet=”left” module_alignment_phone=”left” module_alignment_last_edited=”on|tablet” scroll_rotating_tablet=”65|84|84|100|0\u00b0|15\u00b0|90\u00b0” scroll_rotating_phone=”” scroll_rotating_last_edited=”on|tablet” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.18.0″ _module_preset=”default” background_color=”RGBA(255,255,255,0)” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_menu menu_id=”64″ dropdown_menu_bg_color=”#FFFFFF” dropdown_menu_line_color=”#FFC13F” module_class=”ir-menu-custom” _builder_version=”4.18.0″ _module_preset=”default” menu_text_color=”#555758″ background_color=”RGBA(255,255,255,0)” global_colors_info=”{}”][\/et_pb_menu][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ module_class=”faq-main-section” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” header_text_color=”#1d7ecd” header_font_size=”44px” header_line_height=”1.2em” header_font_size_tablet=”38px” header_font_size_phone=”32px” header_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n

Inbjudan till teckning av units i Saniona AB<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.21.0″ _module_preset=”default” text_font_size=”20px” text_line_height=”1.4em” text_font_size_tablet=”” text_font_size_phone=”18px” text_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n

Bakgrund och motiv<\/h6>\n

Saniona \u00e4r ett epilepsifokuserat biofarmaceutiskt f\u00f6retag i klinisk fas som arbetar med uppt\u00e4ckt och utveckling av nya l\u00e4kemedel genom att modulera jonkanaler. Sanionas interna epilepsi-pipeline omfattar kandidaten SAN711 som \u00e4r redo f\u00f6r kliniska Fas 2-studier f\u00f6r behandling av absenser (en form av epileptiska anfall), den prekliniska utvecklingssubstansen SAN2219 f\u00f6r akuta repetitiva epileptiska anfall och den prekliniska utvecklingssubstansen SAN2355 f\u00f6r behandling av refrakt\u00e4ra fokala anfall.<\/p>\n

Utanf\u00f6r epilepsiomr\u00e5det har Saniona fyra kliniska program som \u00e4r positionerade f\u00f6r partnerskap. Den l\u00e4ngst framskridna kandidaten, tesofensin, har av Sanionas samarbetspartner Medix avancerats mot regulatoriskt godk\u00e4nnande f\u00f6r fetma. Tesomet \u00e4r redo f\u00f6r Fas 2b-studier f\u00f6r s\u00e4llsynta \u00e4tst\u00f6rningar, medan SAN903 \u00e4r redo f\u00f6r Fas 1-studier f\u00f6r inflammatorisk tarmsjukdom och SAN2465 \u00e4r klar f\u00f6r preklinisk utveckling f\u00f6r sv\u00e5r depressiv sjukdom. Saniona har forsknings- och utvecklingspartnerskap med Boehringer Ingelheim GmbH, Medix, AstronauTx Limited och Cephagenix ApS.<\/p>\n

Sanionas mest avancerade patentskyddade jonkanalmodulator \u00e4r SAN711, som utvecklas f\u00f6r behandling av absenser. I juli 2022 rapporterade Bolaget positiva resultat fr\u00e5n en klinisk Fas 1-studie av SAN711 p\u00e5 friska frivilliga f\u00f6rs\u00f6kspersoner. F\u00f6r att s\u00e4kra utvecklingen av SAN711 mot proof-of-concept (studier som genomf\u00f6rs i syfte att p\u00e5visa klinisk relevans) har Saniona beslutat att genomf\u00f6ra F\u00f6retr\u00e4desemissionen.<\/p>\n

F\u00f6retr\u00e4desemissionen i sammandrag<\/h6>\n

F\u00f6retr\u00e4desr\u00e4tt<\/strong>
Varje befintlig aktie i Saniona ber\u00e4ttigar till \u00e5tta (8) unitr\u00e4tter och femton (15) unitr\u00e4tter ber\u00e4ttigar till teckning av en (1) unit best\u00e5ende av tv\u00e5 (2) aktier och en (1) teckningsoption serie TO 4.<\/p>\n

Teckningskurs<\/strong>
4,12 SEK per unit.<\/p>\n

Avst\u00e4mningsdag f\u00f6r deltagande i F\u00f6retr\u00e4desemissionen<\/strong>
18 januari 2024.<\/p>\n

Teckningsperiod<\/strong>
22 januari \u2013 5 februari 2024.<\/p>\n

Handel med unitr\u00e4tter<\/strong>
22 januari \u2013 31 januari 2024.<\/p>\n

Handel med BTU<\/strong>
22 januari 2024 \u2013 fram till dess att F\u00f6retr\u00e4desemissionen har registrerats vid Bolagsverket.<\/p>\n

Teckning och betalning med f\u00f6retr\u00e4desr\u00e4tt<\/strong>
Teckning med st\u00f6d av unitr\u00e4tter sker under teckningsperioden genom samtidig kontant betalning.<\/p>\n

Teckning och betalning utan f\u00f6retr\u00e4desr\u00e4tt<\/strong>
Anm\u00e4lan om teckning utan f\u00f6retr\u00e4desr\u00e4tt ska ske till Vator Securities senast den 5 februari 2024 p\u00e5 s\u00e4rskild anm\u00e4lningssedel som kan erh\u00e5llas fr\u00e5n Sanionas webbplats, www.saniona.com, och p\u00e5 www.vatorsecurities.se. Tilldelade units ska betalas kontant enligt anvisningar p\u00e5 tilldelningsbeskedet. Dep\u00e5kunder hos f\u00f6rvaltare ska ist\u00e4llet anm\u00e4la sig till, och enligt instruktion fr\u00e5n, f\u00f6rvaltaren.<\/p>\n

Dokument 2024<\/strong><\/p>\n

<\/span><\/p>\n

[\/et_pb_text][et_pb_text disabled_on=”on|on|on” _builder_version=”4.21.0″ _module_preset=”default” text_font_size=”20px” text_line_height=”1.4em” text_font_size_tablet=”” text_font_size_phone=”18px” text_font_size_last_edited=”on|phone” disabled=”on” global_colors_info=”{}”]<\/p>\n